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native method for inoculation of laboratory animals or the
use of speciﬁc culture media for routine plaque surveillance
and outbreak investigations.
doi:10.1016/j.ijid.2010.02.427
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Development of a multiplex PCR system with application
of IPC (internal positive control) for detecting Bacillus
anthracis from environmental samples
M. Fallah Raouﬁ1,∗, F. Eini 1, F. Azarifard1, M. Soleimani2, E.
Jamshidiyan1, K. Majidzadeh2
1 Tasnim biotechnology research center, tehran, Iran,
Islamic Republic of
2 Tasnim biotechnology research center, Tehran, Iran,
Islamic Republic of
Background: Bacillus anthracis, the causative agent of
anthrax is a major concern of a dangerous and zoonotic
disease in medicine and veterinary medicine. The develop-
ment of rapid, sensitive and simple techniques to detect
B.anthracis in suspicious specimens is the important aim of
animals and subsequently public health. we described a mul-
tiplex PCR system with application of IPC (internal positive
control) for detecting virulence markers in B.anthracis.
Methods: In PCR assay pag and cap genes located on POX1
and POX2 plasmids were ampliﬁed by use of speciﬁc primers.
In order to control of reaction conditions, we used from PCR
products as a templet and designed IPC for pag and cap genes
that their length was shorter than product segments. After
cloning of PCR products, the sensitivity of the PCR test (limit
of detection) was also estimated. Control bacteria of deﬁned
species was conﬁrmed by ampliﬁcation of a fragment of the
16S rRNA gene by using two universal primers.
Results: In post-PCR stage 591 and 173 bp fragments
of DNA respectively to cap and pag genes recognized in
agarose gel. Sensitivity determination assays revealed that
this method can detect, 412 and 100 copies as LOD for cap
and pag gene respectively in samples.Nonetheless, bands on
the results with negative controls, these genes not present
in these deﬁned bacteria.
Conclusion: In this study, we desigined and optimized a
multiplex PCR assay for the detection and characterization
of B.anthracis from environmental samples. In addition to
we used from IPC to prevention of false negative results and
also to detect inhibitory effects of the sample matrix. The
PCR system described here can be proposed as rapid, safe,
diagnostic and conﬁdent method for detecting anthrax. The
sensitive and speciﬁc nature of this assay provides a valu-
able tool that can be used for analysing clinical and ﬁeld
samples and for improving our understanding of the ecology
and environmental prevalence of B.anthracis in natural foci
of disease.
doi:10.1016/j.ijid.2010.02.428
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B test-kit for rapid drug susceptibility testing ofM. tuber-
ulosis
. Domotenko ∗, M. Khramov
State Research Center for Applied Microbiology & Biotech-
ology, Obolensk, Russian Federation
Background: Drug resistant tuberculosis is an increasing
ublic health concern in many parts of the world, includ-
ng Russia. Traditional drug susceptibility testing is either
ime-consuming (21—28 days for the absolute concentra-
ion method) or expensive (automatic BACTEC systems). In
ontrast, TB test-kit developed at SRCAMB (in the frame of
TEP/DHHS projects #2 and 86) allows for reducing the time
f testing in 2.5 times, has low price and can be used in all
he bacteriological labs.
Methods: Drug susceptibility testing with TB test-kit is
ased on the ability of M. tuberculosis to reduce nitrates
o nitrites. The nitrites are detected with Griess reagent,
hich produces a color change. Sputum or suspension of M.
uberculosis strains inoculates into each a vial of the test-
it with syringe. Then vials of inoculated media incubate at
35± 2) ◦C. In 8—13 days of incubation resistant isolates of
. tuberculosis produce color changes in the vial with an
ppropriate drug. Susceptible isolates does not produce a
olor change.
Results: TB test - kit is a kit of ready-for-use nutrient
edia with drugs or without them and reagent for read-
ng results. The test-kit allows to determine susceptibility
f M. tuberculosis to isoniazid, rifampicin, streptomycin,
thambutol and to perform primary identiﬁcation of M.
uberculosis. The SRCAMB TB test-kit have been tested in
hree clinical laboratories in Russia in comparison with the
bsolute concentration method and the automated BACTEC
GIT 960 using about one thousand M. tuberculosis isolates.
ood agreement between the results of TB test kit and two
echniques was found. In 2008, the RF Ministry of Health
pproved the TB-test kit for production, sale and distribu-
ion at Russian Federation. TB test-kit is currently being
anufactured in SCRAMB and sold by small lots. The basic
onsumers of TB test - kit are mycobacteriological labora-
ories.
Conclusion: Performance of testing with the test-kit does
ot require special equipment and highly skilled personnel.
oi:10.1016/j.ijid.2010.02.429
5.030
roduction and standardization of Brucella national stan-
ard antiserum equivalent to OIEISS in Sudan
.F.E.M. Alawad1,∗, M.T. Musa2
Animal Resources Research corporation, Central
et.Research lab.(CVRL) -Soba, Khartoum, Sudan
Animal Resources Research Corporation, Khartoum, Sudan
Background: Brucellosis is a bacterial contagious zoonotic
isease caused by one of the ninth species of the genus
rucella, including the three proposed new species Brucella
eti, B.pinnipedis (Foster et al., 2002, 2007) and B.microti
Scholz et al., 2008a, 2008b). The serological tests were
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apid and applicable methods for Brucellosis diagnosis using
alidated test methods and standardized reagents. For the
ontrol of brucellosis at the national or local level, the
uffered Brucella antigen tests (Boats), i.e. the Rose Bengal
est (RBT) and the buffered plate agglutination test (BPAT),
s well as the ELISA and the FPA, are suitable screening
ests. Positive reactions should be retested using a suitable
onﬁrmatory and/or complementary strategy (OIE manual,
009). The OIE reference standards are those against which
ll other standards are compared and calibrated. These ref-
rence standards are all available to national reference
aboratories and should be used to establish secondary or
ational standards against which working standards can be
repared and used in the diagnostic laboratory for daily rou-
ine use. These sera have been developed and designated by
he OIE as International Standard Sera. The use of these pro-
otes international harmonisation of diagnostic testing and
ntigen standardisation.
Methods: Sudanese national standard antiserum equiva-
ent to OIEISS was produced and standardised from naturally
nfected cows with a high titre of Brucella according to
eterinary laboratory agency-Webridge Laboratory methods
Hendry et al., 1985) and OIE manual (OIE, 2009). Apanel of
aturally infected cows sera were tested for Brucella Agglu-
inins by RBT, SAT and ELISA.The selected sera and OIEISS
ere titrated, tested and compared with previously men-
ioned serological tests.
Results: An sterile pooled high titre sera were suc-
essfully prepared. The serum was diluted perfectly with
egative serum to match with the OIEISS titre which was
000 IU.
Conclusion: This study was result in production of stan-
ardized National standard antiserum for the ﬁrst time in
udan, when checked locally using the appropriate methods
f Veterinary laboratory agency-Webridge, but needs fur-
her quality control check in the specialist OIE reference
aboratories.
oi:10.1016/j.ijid.2010.02.430
5.031
dentiﬁcation of novel microRNA biomarkers of viral infec-
ion
. Naraghi-Arani1,∗, S. Bavari 2, S. Gardner1, C. Jaing1, J.
hissen1
Lawrence Livermore National Laboratory, Livermore, CA,
SA
United States Army Medical Research Institute of Infec-
ious Diseases, Fredrick, MD, USA
Background: It has become clear in the recent years
hat predictive biomarkers are becoming an integral part
f successful clinical management. Further, a lack of clear
iomarkers has created a real challenge in licensing biode-
ense therapeutics and vaccines. The study presented seeks
o develop tools for the discovery of new microRNA (miRNA)
iomarkers for infectious diseases using advanced compu-
ational tools coupled with high density microarrays and
nimal test facilities to ﬁnd novel miRNA markers of viral
nfection. The system is expected to be of utility to diag-
ostics and vaccine and therapeutics development.
r
dternational Congress on Infectious Diseases (ICID) Abstracts
Methods: Extant software developed for miRNA sequence
ining coupled with supercomputers has been used to ana-
yze the genomes of human, mouse, rhesus macaque, and
ll full-length viral genomes available to identify candidate
iRNAs that may be of utility for detecting viral infections
nd other perturbances of normal metabolic function. These
equences are being incorporated into high density microar-
ays that will be used to assess miRNA expression responses
rom humans, rhesus macaques, and mice for any infec-
ious agent. Initial tests will be conducted on healthy tissue
nd tissue infected with ﬁloviruses to determine miRNA
esponses speciﬁc to ﬁlovirus infection. This system can
lso be used for any other viral infection as well as other
etabolic disturbances not necessarily related to viral infec-
ion and for biomarker discovery related to therapeutics and
accine efﬁcacy testing. The research proposed also aims to
pply, for the ﬁrst time, an miRNA screening tool to discov-
ry of miRNA biomarkers for ﬁlovirus infection.
Results: We have thus far identiﬁed 20442 viral
re-miRNA sequences, and 124292, 90054, and 104037
re-miRNA sequences for humans, macaque, and mouse,
espectively.
Conclusion: Given our preliminary results, we are con-
dent that our experiments seeking to validate these
redicted miRNAs will yield novel markers of infection.
oi:10.1016/j.ijid.2010.02.431
5.032
rocalcitonin as a diagnostic marker in differentiating
acterial from abacterial meningitis
. El-Shamy1,∗, A. Abbass1, Y. Omran2, A. Amine1
High Institute of Public Health, Alexandria, Egypt
Fever Hospital, Alexandria, Egypt
Background: Clinical differentiation of bacterial and
bacterial meningitis is difﬁcult even for experienced
linician, and current laboratory tests cannot distinguish
etween them accurately and rapidly. Therefore, we aimed
o study the role of Procalcitonin (PCT) in differentiating
acterial from abacterial meningitis.
Methods: Patients suspected of having meningitis admit-
ed to Alexandria Fever Hospital were included in the study.
SF and blood samples were collected. CSF samples were
ubjected to microscopic examination, and culture. Blood
amples were used to measure serum PCT level.
Results: Out of the 75 examined cases; equal percentages
42.7%) were deﬁnitely diagnosed as bacterial and abacterial
eningitis cases. Elevated PCT level was found in (81.3%) of
acterial meningitis versus (9.4%) of abacterial meningitis.
CT was the least method of diagnosis to be affected by
readmission antibiotic intake. PCT serum level had a sensi-
ivity of 80.6%, a speciﬁcity of 91.3%, a negative predictive
alue of 93.5%, and a positive predictive value of 75.0%.
Conclusion: Measurement of PCT blood level is a rapid,
imple and speciﬁc test and may be recommended in the
iagnosis of bacterial meningitis cases, especially those who
eceived antibiotic therapy before hospitalization.
oi:10.1016/j.ijid.2010.02.432
